研究発表等（講演・口頭発表等） - 織内 昇
-
Assessment of therapeutic response and prognosis in malignant pleural mesotheliona with 18F-FDG-PET.
22th Annual Congress of the EANM
-
Clinicopathological features of metastasis of liver from rectalcarcinoid determined by F-18-FDG uptake and expression of glucose transporter I and hexokinase Ⅱ
EANM 2009
-
Initial evaluation of [F-18] alfa-methyl tyrosine PET for differential diaguosis of pancreatic lesions
ＳＮＭ2009
-
Bevacizumab based nearinfrared fluorescence imaging of VEGF in colon cancer.
4th Annual meeting of Japanese Society of Molecular imaging (日本分子イメジング学会）
-
Imaging and biodistribution of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small cell lung cancer xenografts.
20th Asia Pacific cancer conference
-
Radioimmuno PET imaging of vascular endothelial growth factor in colon cancer.
22th Annual Congress of the European Association of Nuclear Medicine
-
Targeted imaging with 64Cu trastuzumab PET in non small cell lung cancer.
International Conference on Radiopharmaceutical Therapy (ICRT-2009)
-
Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor.
56th SNM Annual Meeting
-
Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method.
22th Annual Congress of the EANM
-
Can whole body bone SPECT (MIP) with shorter waiting time (90 minutes) replace conventional whole body bone scan without losing lesion detectability?
22th Annual Congress of the EANM
-
Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?
22th Annual Congress of the EANM
-
Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice.
22th Annual Congress of the EANM
-
Clinical usefulness of FDG-PET for the assessment of primary peritoneal cancer.
22th Annual Congress of the EANM
-
Avastin based in vivo imaging of vascular endothelial growth factor in colon cancer.
第4回 日本分子イメージング学会 総会・学術集会
-
[F-18]-α-methyl tyrosine (18F-FMT) Non-FDG PET probe in oncology．
IAEA/RCA regional training course on RTC on Advance Clinical Application of PET
-
Current status of nuclear medicine in Japan．
IAEA
-
Expression of L-type amino acid transporter 1 determined by [18F] fluoro alpha-methyl tyrosine (18F-FMT) PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer ．
56th SNM Annual Meeting 第56回米国核医学会
-
Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor.
56th SNM Annual Meeting
-
Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method.
22th Annual Congress of the EANM
-
Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice.
22th Annual Congress of the EANM